• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

AbbVie Corporation

Member Profile

A company that takes on the toughest health challenges. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.ca and www.abbvie.com. Follow @abbviecanada on Twitter or find us on Facebook, LinkedIn and Instagram

Sector
Global Pharmaceutical Corporations, Therapeutics
Area of Expertise
  • Autoimmune Diseases
  • Drug Discovery
  • Inflammatory Diseases
  • Mental & Behavioral Health
  • Neurological Diseases
  • Oncology
  • Ophthalmology
  • Women’s Health
Company Stage Public Company
Employees outside Canada 46,000 employees
Stock Ticker ABBV - NYSE

Member Profile

Global Pharmaceutical Corporations, Therapeutics

AbbVie Corporation

Bronze Sponsor

  • Website www.abbvie.ca
  • Phone +1 (888) 703 3006
  • Email communications-canada@abbvie.com
  • Address
    8401 Trans-Canada Highway
    Saint-Laurent, QC
    H4S 1Z1
  • Leadership Contact
    Richard A. Gonzalez, Chairman of the Board & CEO
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • News
  • Jobs

January 9, 2023

QULIPTA™ Now Approved by Health Canada for the Preventive Treatment of Episodic Migraine in Adults

November 23, 2022

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Moderate to Severe Active Crohn’s Disease

November 16, 2022

Canadian Migraine Sufferers Have New Treatment Option – Health Canada Approves UBRELVY® (ubrogepant tablet)

November 7, 2022

AbbVie Announces Late-Breaking Results from Phase 2 Exploratory NOVA Trial of Novel Investigational Neurotoxin AGN-151607 for the Prevention of Postoperative Atrial Fibrillation in Cardiac Surgery Patients

October 28, 2022

AbbVie Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Large B-Cell Lymphoma (LBCL)

No current content.

  • Twitter
  • Linkedin
Tweets by AbbVie Corporation
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us